Terry Smith's position in Edwards Lifesciences is currently worth $826 Thousand. That's 0.00% of their equity portfolio (46th largest holding). The investor's estimated purchase price is $960 Thousand, resulting in a loss of 14%.
NEW YORK , Sept. 29, 2021 /PRNewswire/ -- The potential central venous catheters market growth between 2021 and 2025 is USD 138.10 million . The market will ...Benzinga, over 1 year ago
DUBLIN, Jan. 8, 2021 /PRNewswire/ -- The "Central Venous Catheters (Drug Delivery Devices) - Global Market Analysis and Forecast Model (COVID-19 market impac...PR Newswire, about 2 years ago